PRESENTED BY

SP Jaiswal RANBAXY

Introduction

Ranbaxy is the India's largest pharmaceutical company,

Incorporated in 1961. Gurgaon, Haryana, India. Headquarters Located in The company went public in 1973, and Japanese company Daiichi Sankyo gained majority control in 2008 Worldwide Presence
Ground presence in 46 countries, products sold in over 125 countries. Manufacturing locations in 7 countries.

Atul Sobti is currently Ranbaxy CEO and M.D., having taken over from Malvinder Singh in May 2009

History of Ranbaxy
Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1960 as a distributor for a Japanese company Shionog i.
The name Ranbaxy is a portmanteau word from the names of its first owners Ranbir and Gurbax.

Bhai Mohan Singh bought the company in 1966 and after that Mohan Singh and Shivinder Mohan Singh and after that the company emerged to the Japanese company Daiichi Sankyo in June 2008.

CORPORATE OFFICE

Mission
To become a Research-based International Pharmaceutical Company

Vision 2012
Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets

siblecorp envi Man partn Fos shar Ens oppo Prac Pro
value
Achieving customer satisfaction is

Achieving customer satisfaction is fundamental of business Provide products and services of the highest quality Ensure profitable growth and enhance wealth of the shareholders Foster mutually beneficial relations with all our business partners

Manage our operations with high concern for safety and Environment
Be a responsible corporate citizen

Ranbaxy Daiichi Sankyo Partnership Ranbaxy Daiichi Sankyo Partnership

Provides solutions to key need-gaps for each organization.

Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse.

Financially & strategically beneficial for all stakeholders

Corporate Social Responsibility

CREATING VALUE VALUING LIFE An essential component of Ranbaxy's CSR is to care for the community. Based on the theme Health For All setup Ranbaxy Rural Development Trust in 1978; Operates in the states of Punjab, Haryana, H.P.,MP.and Delhi /Gurgaon to provide integrated health care to about 2 lakh people staying in 100 villages and urban slum areas..

Chairman, CEO & M.D.

Dr. Tsutomu Une Chairman

Malvinder Mohan Singh CEO & M. D.

Board of Directors

Board of Directors

Dr. Tsutomu Une Mr. Takashi Shoda

Chairman Non Executive & Non Executive & Non Independent Non Independent Director Director

Mr. Atul Sobti

CEO & MD

Mr. Rajesh V. Shah

Independent Director

Dr. Anthony H. Wild

Independent Director

Mr. Rajesh V. Shah

Independent Director

Mr. Percy Shroff

Independent Director

Ranbaxys Top Products

Simvastatin Control hyperchol esterolemia & to prevent cardiovascular
disease

AmoxiClav Potassium
Used to treat a broad-spectrum of bacterial infections,

Isotretinoin
for the treatment of brain cancer, pancreatic cancer

Ciprofloxacin
It kills bacteria by interfering

Omeprazole
used in the treatment of dyspepsia

Global Sales Split CIS

Asia

North America ROW Europe

API

Global Sales (2009): US $ 1519 Mn

Market Share of Ranbaxy

Global Markets Mix 2008
54% & Emerging

The Company is currently ranked 2nd in the Indian pharmaceutical market with 4.98% market share (IMS, OctDec09). Global sales in 2009 were USD 1,519 Mn (Rs. 73,441 Mn), De-growth of 9% over previous year. In Rupee terms, sales grew moderately by 1%. Sales during the Quarter recorded growth of 25% at USD 482 Mn (Rs. 22,699 Mn). Emerging markets accounted for 54% of sales during the year, while developed markets contributed 39%

Key competitors
Glaxo Smith Kline

RPG Enterprises

East India Pharmaceutica

Dr. Reddys Laboratorie

Cipla Ltd
Dabur India ltd

Ranbaxy Laboratories Limited

Plot 90, Sector 32,

Corporate Office

Gurgaon -122001 (Haryana), INDIA

Ph: 91- 124- 4135000 Fax: 91-124-4135001

Web site:-www.ranbaxy.com

THANK YOU